Last reviewed · How we verify
NCT05053620: ARCUATAS
Astigmatism Correction With Intrastromal Arcuate Incisions in Eyes Undergoing Cataract Surgery With Femtosecond Laser Using the Cassini Ambient With Iris Registration (ARCUATAS)
trial testing Calculation of the arcuate intrasomal incisions in Cataract in 22 participants. Completed in 18 April 2023.
18 April 2023
Quick facts
| Lead sponsor | OFTALVIST (Oftalmología Vistahermosa S.L) |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 22 |
| Start date | 19 October 2021 |
| Primary completion | 18 April 2023 |
| Estimated completion | 18 April 2023 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Calculation of the arcuate intrasomal incisions
Conditions studied
- Cataract — all drugs for Cataract →
- Astigmatism — all drugs for Astigmatism →
Sponsor
OFTALVIST (Oftalmología Vistahermosa S.L)
Who can join
18 and older, any sex, with Cataract or Astigmatism. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is an observational, prospective follow-up post-marketing study of CE marked medical devices aimed at treating astigmatism in patients with cataracts. The main objective is to evaluate the response of the intrastromal arcuate incisions procedure for the correction of low corneal astigmatism with the Catalys femtosecond laser using the Cassini Ambient equipment with iris registration in cataract surgery.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05053620
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cataract
Currently open trials in the same condition.
- NCT07301385 — Evaluation of Head-Mounted Spatial Computing and Three-Dimensional (3D) Visualization in Ocular Microsurgery: A Safety a · NA · recruiting
- NCT07462000 — Aqueous Humor and Ocular Tissue Analysis in Glaucoma and Cataract · NA · recruiting
- NCT06891092 — Vivinex Impress XY1-EM vs RayOne EMV · NA · recruiting
- NCT07218796 — Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compar · Phase 3 · recruiting
- NCT07218783 — Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compar · Phase 3 · recruiting
Other OFTALVIST (Oftalmología Vistahermosa S.L) trials
Trials by the same sponsor.
- NCT05239715 — Evaluation of Three SS-OCT and One PCI Optical Biometers in Eyes With Dense Cataract · completed
- NCT05058274 — Clinical Results of a Monofocal Aspheric Bitoric Intraocular Lens With Plate Haptics in Hyperopic Eyes (HIPER-AT-TORBI) · completed
- NCT04875247 — IOLMASTER 700 Central Topography Workflow Study. · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05053620 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by OFTALVIST (Oftalmología Vistahermosa S.L)
- Last refreshed: 22 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05053620.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing